Timing of IABP initiation and its impact on outcomes in acute myocardial infarction with cardiogenic shock: insights from a bi-center retrospective study - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Influence of IABP Start Timing on Outcomes in Acute Myocardial Infarction with Cardiogenic Shock: Findings from a Bi-Center Retrospective Analysis

  • By

  • Istvan Bojti

  • Sarolta Bojtine Kovacs

  • David Kovacs

  • Antonia Ziegler

  • Alexander Maier

  • Dirk Westermann

  • Miroslaw Ferenc

  • Attila Csaba Nagy

  • Kalman Racz

  • Zsolt Koszegi

  • Gabor Tamas Szabo

  • June 8, 2026

Share

Objective:

To investigate the impact of intra-aortic balloon pump (IABP) initiation timing and the extent of myocardial area at risk on clinical outcomes in patients with acute myocardial infarction complicated by cardiogenic shock, emphasizing their interrelationship.

Approach:
    Key Findings:
    • Early initiation of IABP may improve survival outcomes in patients with acute myocardial infarction complicated by cardiogenic shock, suggesting a need for timely intervention.
    • The extent of the myocardial area at risk is a critical factor influencing the effectiveness of IABP support, highlighting the importance of patient selection.
    • Current guidelines lack sufficient evidence on the optimal timing and patient selection for IABP in acute myocardial infarction complicated by cardiogenic shock, necessitating further research.
    Interpretation:

    The study underscores the urgent need for further investigation into the timing of IABP initiation and its relationship with the area at risk in patients with acute myocardial infarction complicated by cardiogenic shock to optimize treatment strategies.

    Limitations:
    • Retrospective design may introduce selection bias and confounding factors.
    • Data were collected from two centers, which may limit generalizability.
    Conclusion:

    Further research is warranted to clarify the optimal timing for IABP initiation in AMI-CS patients and its impact on clinical outcomes.

Original Source(s)

Related Content